-
Faced with limited data about acute mountain sickness in children who travelled rapidly to high altitudes, Swiss researchers studied symptoms in 48 children (ages 10-17, mean age 13) who traveled 2.5 hours from low altitude (568 meters) to 3,450 meters (approximately 11,200 feet).
-
In this issue: Individualization of therapy with pharmacogenetics; the rate vs rhythm debate; the FDA's Risk Evaluation and Mitigation Strategy; FDA actions.
-
In older women and men, all low-trauma fractures were associated with increased mortality risk for at least 5 years. Subsequent fracture increased that risk.
-
Eltrombopag is a thrombopoietin (TPO) receptor agonist approved by the FDA for the treatment of thrombocytopenia.
-
The women's health initiative (WHI) provided convincing evidence that the use of estrogen plus progesterone (E+P) in postmenopausal women is associated with an increased risk of breast cancer.
-
The ECG shown above was a baseline tracing obtained during the initial visit with a new primary care provider. How would you interpret the tracing? What do you suspect happened in the past?
-
This is the first study documenting that a PPI compromises the mucosal barrier function of the upper GI tract.
-
It has been very difficult to study the effects of alcohol on the fetus and on pregnancy, in general, because one depends so heavily on a patient's candor regarding true alcohol consumption and the effect of confounding variables, such as smoking.
-
The standard primary surgical intervention for early-stage uterine cancer is hysterectomy, usually with removal of the adnexa.
-
The livial intervention following breast cancer: Efficacy, Recurrence, And Tolerability Endpoints (LIBERATE) trial was a multinational, placebo-controlled, randomized study of women with vasomotor symptoms who had had breast cancer surgically treated within the previous 5 years.
